. 2019 Jan 11;58(7):997–1009. doi: 10.1021/acs.biochem.8b01085
Copyright © 2019 American Chemical Society
This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
Figure 1.
Structures of FDA-approved β-lactamase inhibitors.